Pierre‐françois Plouin
#163,119
Most Influential Person Now
Pierre‐françois Plouin's AcademicInfluence.com Rankings
Pierre‐françois Plouinmedical Degrees
Medical
#3313
World Rank
#3780
Historical Rank
Cardiology
#344
World Rank
#355
Historical Rank

Pierre‐françois Plouinphilosophy Degrees
Philosophy
#9481
World Rank
#13047
Historical Rank
Logic
#6454
World Rank
#7972
Historical Rank

Download Badge
Medical Philosophy
Pierre‐françois Plouin's Degrees
- Doctorate Medicine Université Paris Cité
- PhD Cardiology Université Paris Cité
Why Is Pierre‐françois Plouin Influential?
(Suggest an Edit or Addition)Pierre‐françois Plouin's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Evidence for an increased rate of cardiovascular events in patients with primary aldosteronism. (2005) (1384)
- Genetic testing in pheochromocytoma or functional paraganglioma. (2005) (621)
- Clinical presentation and penetrance of pheochromocytoma/paraganglioma syndromes. (2006) (537)
- Mutations in the SDHB gene are associated with extra-adrenal and/or malignant phaeochromocytomas. (2003) (513)
- Somatic mutations in ATP1A1 and ATP2B3 lead to aldosterone-producing adenomas and secondary hypertension (2013) (464)
- Optimum and stepped care standardised antihypertensive treatment with or without renal denervation for resistant hypertension (DENERHTN): a multicentre, open-label, randomised controlled trial (2015) (434)
- Stent placement in patients with atherosclerotic renal artery stenosis and impaired renal function: a randomized trial. (2009) (433)
- An Expert Consensus Statement on Use of Adrenal Vein Sampling for the Subtyping of Primary Aldosteronism (2014) (403)
- Succinate dehydrogenase B gene mutations predict survival in patients with malignant pheochromocytomas or paragangliomas. (2007) (372)
- Cardiovascular Complications Associated With Primary Aldosteronism: A Controlled Cross-Sectional Study (2013) (369)
- The R22X mutation of the SDHD gene in hereditary paraganglioma abolishes the enzymatic activity of complex II in the mitochondrial respiratory chain and activates the hypoxia pathway. (2001) (357)
- The succinate dehydrogenase genetic testing in a large prospective series of patients with paragangliomas. (2009) (347)
- Year of diagnosis, features at presentation, and risk of recurrence in patients with pheochromocytoma or secreting paraganglioma. (2005) (331)
- Masked hypertension: a systematic review. (2008) (297)
- The Adrenal Vein Sampling International Study (AVIS) for identifying the major subtypes of primary aldosteronism. (2012) (293)
- Molecular markers and long-term recurrences in a large cohort of patients with sporadic adrenocortical tumors. (2001) (291)
- MAX Mutations Cause Hereditary and Sporadic Pheochromocytoma and Paraganglioma (2012) (284)
- Integrative genomic analysis reveals somatic mutations in pheochromocytoma and paraganglioma. (2011) (277)
- SDHA immunohistochemistry detects germline SDHA gene mutations in apparently sporadic paragangliomas and pheochromocytomas. (2011) (270)
- Prevalence, Clinical, and Molecular Correlates of KCNJ5 Mutations in Primary Aldosteronism (2012) (242)
- Structural and functional abnormalities at 11p15 are associated with the malignant phenotype in sporadic adrenocortical tumors: study on a series of 82 tumors. (1997) (235)
- The Warburg Effect Is Genetically Determined in Inherited Pheochromocytomas (2009) (225)
- Gene expression profiling of human adrenocortical tumors using complementary deoxyribonucleic Acid microarrays identifies several candidate genes as markers of malignancy. (2005) (223)
- Functional consequences of a SDHB gene mutation in an apparently sporadic pheochromocytoma. (2002) (206)
- Efficacy of Revascularization For Renal Artery Stenosis Caused by Fibromuscular Dysplasia: A Systematic Review and Meta-Analysis (2010) (206)
- Blood pressure loci identified with a gene-centric array. (2011) (177)
- KCNJ5 Mutations in European Families With Nonglucocorticoid Remediable Familial Hyperaldosteronism (2012) (171)
- European consensus on the diagnosis and management of fibromuscular dysplasia. (2014) (165)
- Multi-omics analysis defines core genomic alterations in pheochromocytomas and paragangliomas (2015) (160)
- Gene polymorphisms of the renin‐angiotensin system in relation to hypertension and parental history of myocardial infarction and stroke: the PEGASE study (1998) (152)
- Fibromuscular Dysplasia of Cervical and Intracranial Arteries (2010) (152)
- Continuing uncertainty about the value of percutaneous revascularization in atherosclerotic renovascular disease: a meta-analysis of randomized trials. (2003) (150)
- WNT/β-catenin signalling is activated in aldosterone-producing adenomas and controls aldosterone production. (2014) (149)
- Phaeochromocytoma, new genes and screening strategies (2006) (147)
- A clinical prediction score to diagnose unilateral primary aldosteronism. (2012) (147)
- Validation of a French Version of the 8‐Item Morisky Medication Adherence Scale in Hypertensive Adults (2012) (146)
- Aldosterone Synthase Inhibition With LCI699: A Proof-of-Concept Study in Patients With Primary Aldosteronism (2010) (141)
- Angiogenesis and vascular architecture in pheochromocytomas: distinctive traits in malignant tumors. (2002) (139)
- Sequential nephron blockade versus sequential renin–angiotensin system blockade in resistant hypertension: a prospective, randomized, open blinded endpoint study (2012) (136)
- PHACTR1 Is a Genetic Susceptibility Locus for Fibromuscular Dysplasia Supporting Its Complex Genetic Pattern of Inheritance (2016) (136)
- Isocitrate dehydrogenase mutations are rare in pheochromocytomas and paragangliomas. (2010) (136)
- [Diagnosis and classification of diabetes mellitus: the new criteria]. (1999) (133)
- First international consensus on the diagnosis and management of fibromuscular dysplasia. (2019) (129)
- Possible familial origin of multifocal renal artery fibromuscular dysplasia (1997) (128)
- Imaging work-up for screening of paraganglioma and pheochromocytoma in SDHx mutation carriers: a multicenter prospective study from the PGL.EVA Investigators. (2013) (126)
- Trends in the prevalence of primary aldosteronism, aldosterone-producing adenomas, and surgically correctable aldosterone-dependent hypertension. (2004) (122)
- Adherence to Antihypertensive Treatment and the Blood Pressure–Lowering Effects of Renal Denervation in the Renal Denervation for Hypertension (DENERHTN) Trial (2016) (122)
- Adrenal Cortex Remodeling and Functional Zona Glomerulosa Hyperplasia in Primary Aldosteronism (2010) (120)
- Association Between 2 Angiographic Subtypes of Renal Artery Fibromuscular Dysplasia and Clinical Characteristics (2012) (116)
- Diabetes as a marker of pheochromocytoma in hypertensive patients (2003) (115)
- Fasting Plasma Glucose and Serum Lipids in Patients With Primary Aldosteronism: A Controlled Cross-Sectional Study (2009) (113)
- Treatment of malignant pheochromocytoma. (2009) (112)
- Diagnosis and management of fibromuscular dysplasia: an expert consensus (2012) (111)
- High Prevalence of Multiple Arterial Bed Lesions in Patients With Fibromuscular Dysplasia: The ARCADIA Registry (Assessment of Renal and Cervical Artery Dysplasia) (2017) (107)
- Metastatic Pheochromocytoma and Paraganglioma: Focus on Therapeutics (2012) (106)
- First International Consensus on the diagnosis and management of fibromuscular dysplasia (2019) (104)
- Head and neck paragangliomas in von Hippel-Lindau disease and multiple endocrine neoplasia type 2. (2009) (103)
- Blood pressure outcome of adrenalectomy in patients with primary hyperaldosteronism with or without unilateral adenoma (2008) (101)
- Acute catecholamine cardiomyopathy in patients with phaeochromocytoma or functional paraganglioma (2013) (101)
- Laparoscopic management of primary hyperaldosteronism: clinical experience with 212 cases. (2003) (100)
- Diagnostic accuracy of free and total metanephrines in plasma and fractionated metanephrines in urine of patients with pheochromocytoma. (2010) (96)
- Blood pressure and renal outcomes in patients with kidney infarction and hypertension (2006) (95)
- Comparison of nurse‐ and physician‐determined clinic blood pressure levels in patients referred to a hypertension clinic: implications for subsequent management (2000) (92)
- Inheritance of arterial lesions in renal fibromuscular dysplasia (2007) (92)
- One-year progression-free survival of therapy-naive patients with malignant pheochromocytoma and paraganglioma. (2013) (91)
- Pheochromocytomas and secreting paragangliomas (2006) (90)
- Comparison of antihypertensive efficacy and perinatal safety of labetalol and methyldopa in the treatment of hypertension in pregnancy: a randomized controlled trial (1988) (89)
- The benefit of STent placement and blood pressure and lipid-lowering for the prevention of progression of renal dysfunction caused by Atherosclerotic ostial stenosis of the Renal artery. The STAR-study: rationale and study design. (2003) (89)
- Renin secreting tumors: diagnosis, conservative surgical approach and long-term results. (1995) (89)
- Epithelial to mesenchymal transition is activated in metastatic pheochromocytomas and paragangliomas caused by SDHB gene mutations. (2012) (86)
- Aldosterone-producing adenoma formation in the adrenal cortex involves expression of stem/progenitor cell markers. (2011) (84)
- The Urinary Metanephrine-to-Creatinine Ratio for the Diagnosis of Pheochromocytoma (1996) (84)
- Left ventricular mass and geometry before and after etiologic treatment in renovascular hypertension, aldosterone-producing adenoma, and pheochromocytoma. (1993) (84)
- Factors predictive of attendance at clinic and blood pressure control in hypertensive patients. (1983) (79)
- Angiotensin‐converting enzyme inhibitors during pregnancy: a survey of 22 patients given captopril and nine given enalapril (1988) (78)
- Aldosterone-producing adenoma and other surgically correctable forms of primary aldosteronism (2010) (73)
- Rationale for Anti-angiogenic Therapy in Pheochromocytoma and Paraganglioma (2012) (73)
- Biochemical tests for diagnosis of phaeochromocytoma: urinary versus plasma determinations. (1981) (72)
- Split renal function outcome after renal angioplasty in patients with unilateral renal artery stenosis. (2001) (72)
- TMEM127 screening in a large cohort of patients with pheochromocytoma and/or paraganglioma. (2012) (69)
- Revisiting Fibromuscular Dysplasia: Rationale of the European Fibromuscular Dysplasia Initiative. (2016) (63)
- Association of Smoking With Phenotype at Diagnosis and Vascular Interventions in Patients With Renal Artery Fibromuscular Dysplasia (2013) (62)
- Identification of potential gene markers and insights into the pathophysiology of pheochromocytoma malignancy. (2007) (61)
- [Screening for phaeochromocytoma : in which hypertensive patients? A semiological study of 2585 patients, including 11 with phaeochromocytoma (author's transl)]. (1981) (60)
- Identification of the secretogranin II-derived peptide EM66 in pheochromocytomas as a potential marker for discriminating benign versus malignant tumors. (2003) (59)
- Benefits of a computer-assisted education program for hypertensive patients compared with standard education tools. (1994) (58)
- Eligibility for renal denervation in patients with resistant hypertension: when enthusiasm meets reality in real-life patients. (2012) (55)
- RECENT ADVANCES IN THE GENETICS OF PHAEOCHROMOCYTOMA AND FUNCTIONAL PARAGANGLIOMA (2008) (54)
- Structural analysis and evaluation of the 11β‐hydroxysteroid dehydrogenase type 2 (11β‐HSD2) gene in human essential hypertension (1998) (54)
- Initial work-up and long-term follow-up in patients with phaeochromocytomas and paragangliomas. (2006) (52)
- Spontaneous renal artery dissection: long-term outcomes after endovascular stent placement. (2009) (51)
- Expression profile of serotonin4 (5-HT4) receptors in adrenocortical aldosterone-producing adenomas. (2005) (50)
- Influence of Diagnostic Criteria on the Interpretation of Adrenal Vein Sampling (2015) (49)
- A novel TMEM127 mutation in a patient with familial bilateral pheochromocytoma. (2011) (49)
- Differences in emotion processing in patients with essential and secondary hypertension. (2010) (47)
- Gene expression profiling of human adrenocortical tumors using cDNA microarrays identifies several candidate genes as markers of malignancy (2004) (47)
- HYPERTENSIVE CRISIS IN PATIENT WITH PHÆOCHROMOCYTOMA GIVEN METOCLOPRAMIDE (1976) (47)
- Effects of slow‐release octreotide on urinary metanephrine excretion and plasma chromogranin A and catecholamine levels in patients with malignant or recurrent phaeochromocytoma (2002) (47)
- Disruption of the elastin gene in adult Williams syndrome is accompanied by a paradoxical reduction in arterial stiffness. (2002) (47)
- Clinical and biochemical characteristics of normotensive patients with primary aldosteronism: a comparison with hypertensive cases (2008) (46)
- Renal artery stent placement: immediate and midterm technical and clinical results. (1994) (46)
- Fibromuscular dysplasia (2007) (46)
- CYCLOSPORINE‐INDUCED STIMULATION OF THE RENIN‐ANGIOTENSIN SYSTEM AFTER LIVER AND HEART TRANSPLANTATION (1993) (45)
- Short‐term effects of octreotide on blood pressure and plasma catecholamines and neuropeptide Y levels in patients with phaeochromocytoma: a placebo‐controlled trial (1995) (45)
- Socioeconomic Status and Hypertension Control in Sub-Saharan Africa: The Multination EIGHT Study (Evaluation of Hypertension in Sub-Saharan Africa) (2018) (42)
- Blunt renal trauma-induced hypertension: prevalence, presentation, and outcome. (2006) (42)
- Evidence for carotid and radial artery wall subclinical lesions in renal fibromuscular dysplasia (2003) (42)
- Blood pressure and medication changes following adrenalectomy for unilateral primary aldosteronism: a follow-up study (2012) (42)
- Comparison of the hormonal and renal effects of captopril in severe essential and renovascular hypertension. (1982) (42)
- Comparison of the antihypertensive and hormonal effects of a cardioselective beta-blocker, acebutolol, and diuretics in essential hypertension. (1978) (41)
- Fibromuscular Dysplasia and Its Neurologic Manifestations: A Systematic Review (2019) (40)
- Diagnosis and treatment of renal artery stenosis (2010) (39)
- The Non–Insulin-Dependent Diabetes, Hypertension, Microalbuminuria or Proteinuria, Cardiovascular Events, and Ramipril (DIABHYCAR) Study: Design, Organization, and Patient Recruitment (2000) (39)
- Hypertension management: the computer as a participant. (1980) (39)
- Exome sequencing in seven families and gene-based association studies indicate genetic heterogeneity and suggest possible candidates for fibromuscular dysplasia (2015) (38)
- MANAGEMENT OF ENDOCRINE DISEASE: Recurrence or new tumors after complete resection of pheochromocytomas and paragangliomas: a systematic review and meta-analysis. (2016) (38)
- Fighting fake medicines: First quality evaluation of cardiac drugs in Africa. (2017) (37)
- Relative Expression of the RET9 and RET51 Isoforms in Human Pheochromocytomas (2000) (35)
- SFE/SFHTA/AFCE primary aldosteronism consensus: Introduction and handbook. (2016) (35)
- α1-antitrypsin gene polymorphisms are not associated with renal arterial fibromuscular dysplasia (2006) (34)
- Sequential comparison of aldosterone synthase inhibition and mineralocorticoid blockade in patients with primary aldosteronism (2013) (33)
- Mast cell hyperplasia is associated with aldosterone hypersecretion in a subset of aldosterone-producing adenomas. (2015) (31)
- Glucagon receptor gene mutation (Gly40Ser) in human essential hypertension: the PEGASE study. (1999) (31)
- Would wider screening for primary aldosteronism give any health benefits? (2004) (31)
- Atherosclerotic renovascular disease: beyond the renal artery stenosis. (2007) (30)
- Hypertension and aortorenal disease in Alagille syndrome (2012) (28)
- Abdominal Aortic Calcifications Influences the Systemic and Renal Hemodynamic Response to Renal Denervation in the DENERHTN (Renal Denervation for Hypertension) Trial (2017) (28)
- Presentation and revascularization outcomes in patients with radiation-induced renal artery stenosis. (2001) (28)
- Circulating EM66 is a highly sensitive marker for the diagnosis and follow‐up of pheochromocytoma (2006) (28)
- Peritoneal implantation of pheochromocytoma following tumor capsule rupture during surgery. (2014) (27)
- [Recent advances in the clinical study of the renin system. Reference values and conditions of validity]. (1989) (27)
- Use of a standardized personal medical record by patients with hypertension: a randomized controlled prospective trial. (1995) (26)
- Steroidogenesis in aldosterone-producing adenoma revisited by transcriptome analysis. (2005) (26)
- Metoclopramide stimulates catecholamine- and granin-derived peptide secretion from pheochromocytoma cells through activation of serotonin type 4 (5-HT4) receptors. (2008) (26)
- Cause of renal infarction: a retrospective analysis of 186 consecutive cases (2017) (26)
- Changes in Urinary Total Metanephrine Excretion in Recurrent and Malignant Pheochromocytomas and Secreting Paragangliomas (2006) (25)
- The genetic basis of pheochromocytoma: who to screen and how? (2006) (25)
- Development of Novel Tools for the Diagnosis and Prognosis of Pheochromocytoma Using Peptide Marker Immunoassay and Gene Expression Profiling Approaches (2006) (25)
- Telmisartan vs losartan plus hydrochlorothiazide in the treatment of mild-to-moderate essential hypertension—a randomised ABPM study (2003) (25)
- Phaeochromocytomas and functional paragangliomas: clinical management. (2010) (25)
- [Conn's adenoma. Diagnostic and prognostic value of the measurement of potassium, renin, aldosterone levels and the aldosterone/renin ratio]. (1995) (25)
- EUROPEAN SOCIETY OF HYPERTENSION EXCELLENCE CENTRES (2007) (25)
- Recent developments in pheochromocytoma diagnosis and imaging. (1988) (25)
- Expression of trophic amidated peptides and their receptors in benign and malignant pheochromocytomas: high expression of adrenomedullin RDC1 receptor and implication in tumoral cell survival. (2010) (25)
- ACE inhibitors, cough, and genetics (1994) (25)
- Fetal growth retardation in gestational hypertension: relationships with blood pressure levels and the time of onset of hypertension. (1983) (24)
- Management of the patient with atherosclerotic renal artery stenosis. New information from randomized trials. (1999) (24)
- Localization and characterization of evolutionarily conserved chromogranin A-derived peptides in the rat and human pituitary and adrenal glands (2002) (24)
- Clinical management of renal artery fibromuscular dysplasia: temporal trends and outcomes (2014) (23)
- Primary stenting for atherosclerotic renal artery stenosis. (2010) (23)
- Stable patients with atherosclerotic renal artery stenosis should be treated first with medical management. (2003) (22)
- THE EUROPEAN/INTERNATIONAL FIBROMUSCULAR DYSPLASIA REGISTRY AND INITIATIVE (FEIRI)- CLINICAL PHENOTYPES AND THEIR PREDICTORS BASED ON A COHORT OF ONE THOUSAND PATIENTS. (2020) (21)
- Assessment of serum sodium to urinary sodium divided by (serum potassium)² to urinary potassium as a screening tool for primary aldosteronism (2011) (20)
- Expression and Processing of the Neuroendocrine Protein Secretogranin II in Benign and Malignant Pheochromocytomas (2006) (20)
- Suppression of Aldosterone Secretion After Recumbent Saline Infusion Does Not Exclude Lateralized Primary Aldosteronism (2016) (20)
- The non-insulin-dependent diabetes, hypertension, microalbuminuria or proteinuria, cardiovascular events, and ramipril (DIABHYCAR) study: design, organization, and patient recruitment. DIABHYCAR Study Group. (2000) (20)
- High levels of tyrosine phosphorylated proto-ret in sporadic phenochromocytomas. (2000) (20)
- Polymorphic differences from normal in the aldosterone synthase gene (CYP11B2) in patients with primary hyperaldosteronism and adrenal tumour (Conn's syndrome) (2001) (20)
- Greater efficacy of aldosterone blockade and diuretic reinforcement vs. dual renin–angiotensin blockade for left ventricular mass regression in patients with resistant hypertension (2014) (20)
- [Inhibition of angiotensin converting enzyme in human pregnancy. 15 cases]. (1985) (19)
- Plasma renin activity in phaeochromocytoma: effects of beta-blockade and converting enzyme inhibition. (1988) (19)
- Primary adrenal angiosarcoma and functioning adrenocortical adenoma: an exceptional combined tumor. (2012) (19)
- Design of the Omapatrilat in Persons with Enhanced Risk of Atherosclerotic events (OPERA) trial. (2002) (18)
- Diagnostic biochimique du phéochromocytome et du neuroblastome (2002) (18)
- Risk of fetal growth retardation as a result of maternal hypertension. Preparation to a trial on antihypertensive drugs. (1982) (18)
- Eligibility for Renal Denervation: Anatomical Classification and Results in Essential Resistant Hypertension (2015) (18)
- Proteinuria in renal artery occlusion is related to active renin concentration and contralateral kidney size (2002) (18)
- Is Primary Aldosteronism Underdiagnosed In Clinical Practice? (2001) (18)
- INFLUENCE OF BLOOD SAMPLING PROCEDURE ON PLASMA CONCENTRATIONS OF MATRIX METALLOPROTEINASES AND THEIR TISSUE INHIBITORS (2008) (18)
- [Angiotensin II receptor blockers: current status and future prospects]. (2002) (18)
- Outcomes of drug-based and surgical treatments for primary aldosteronism. (2015) (17)
- Substandard drugs among five common antihypertensive generic medications: an analysis from 10 African countries (2018) (17)
- How much can blood pressure be lowered? (1983) (17)
- [Biochemical diagnosis of pheochromocytoma and neuroblastomas]. (2002) (17)
- Frequency and perinatal consequences of hypertensive disease of pregnancy. (1986) (16)
- Combination therapy with candesartan cilexetil plus hydrochlorothiazide in patients unresponsive to low-dose hydrochlorothiazide. (1997) (16)
- [Von Hippel-Lindau disease: recent genetic progress and patient management. Francophone Study Group of von Hippel-Lindau Disease (GEFVH)]. (1998) (16)
- The application of molecular genetics to the study of familial arterial hypertension. (1990) (15)
- SFE/SFHTA/AFCE consensus on primary aldosteronism, part 4: Subtype diagnosis. (2016) (15)
- Hypocaloric diet and antihypertensive drug treatment. A randomized controlled clinical trial. (1993) (14)
- Interactive electronic teaching (ISIS): has the future started? (1996) (14)
- Long-term experience of spironolactone in essential hypertension. (1988) (14)
- A clinical approach to the management of a patient with suspected renovascular disease who presents with leg ischemia. (2003) (14)
- [Detection, diagnosis and localization of pheochromocytoma. 77 cases in a population of 21,420 hypertensive patients]. (1987) (14)
- Structural analysis and evaluation of the 11beta-hydroxysteroid dehydrogenase type 2 (11beta-HSD2) gene in human essential hypertension. (1998) (14)
- SAH gene variants are associated with obesity-related hypertension in Caucasians: the PEGASE Study (2007) (13)
- Individualization of antihypertensive therapy. (1988) (13)
- Rare loss-of-function mutations of PTGIR are enriched in fibromuscular dysplasia (2020) (13)
- Sex differences in antihypertensive treatment in France among 17 856 patients in a tertiary hypertension unit (2018) (13)
- Factors predictive of perinatal outcome in pregnancies complicated by hypertension. (1986) (13)
- Endovascular Renal Artery Denervation: Why, When, and How? (2012) (13)
- [Localization of primary hyperaldosteronism]. (1988) (12)
- Hypertension artérielle endocrine (2010) (12)
- The Long-Term Effectiveness of Preventive Strategies for Osteoporosis in Postmenopausal Women: A Modeling Approach (2000) (12)
- Cardiovascular risk factors in hypertensive patients born in Northern Africa and living in France (2010) (12)
- Progress in primary aldosteronism. Mineralocorticoid antagonist treatment for aldosterone-producing adenoma. (2015) (12)
- Molecular Biology as a Tool for Genetic Research in Hypertension: Application to the Renin Gene (1988) (12)
- [Hyperaldosteronism sensitive to dexamethasone with adrenal adenoma. Clinical, biological and genetic study]. (1995) (12)
- Poor adherence to medication and salt restriction as a barrier to reaching blood pressure control in patients with hypertension: Cross-sectional study from 12 sub-Saharan countries. (2020) (12)
- [COMETE, a network for the study and management of hypersecreting adrenal tumors]. (2008) (11)
- [Hypertension in the elderly]. (2006) (10)
- Simultaneous measurement of beta-endorphin, lipotrophins and met-enkephalin in phaeochromocytomas. (1982) (10)
- [Recent progress in the diagnosis, prognostic evaluation and treatment of pheochromocytomas]. (2000) (9)
- A6 - Short term effects of octreotide on blood pressure and plasma catecholamines and neuropeptidey levels in patients with pheochromocytoma: A placebo-controlled trial (1995) (9)
- Dose Dependency of Captopril Effects in Severely Hypertensive Patients (1981) (9)
- Phaeochromocytoma revealed by type A acute aortic dissection. (1994) (9)
- Automated interpretation of home blood pressure assessment (Hy-Result software) versus physician’s assessment: a validation study (2016) (9)
- HY-Quest, standardized patient questionnaire to be completed at home before a first visit for hypertension: a validation study in specialized centres in France (2014) (9)
- Are angiotensin converting enzyme inhibition and aldosterone antagonism equivalent in hypertensive patients over fifty? (1991) (8)
- Primary Aldosteronism vidence for an Increased Rate of Cardiovascular vents in Patients With Primary Aldosteronism (2005) (8)
- [Tumors of both adrenal glands. 12 consecutive cases]. (1994) (8)
- Hypokalemia, aldosteronism, and renal cysts. (1990) (8)
- Deciphering the Role of Vasopressin in Primary Aldosteronism. (2015) (8)
- Hypertension management: the role of the computer in improving patient compliance. (1982) (8)
- [Hypertension and primary hyperaldosteronism]. (2000) (8)
- [Arterial hypertension secondary to curable causes in adults]. (2002) (7)
- [Hypertensive disease in subjects born in sub-Saharan Africa or in Europe referred to a hypertension unit: a cross-sectional study]. (2007) (7)
- Building a Semantic Interoperability Framework for Care and Research in Fibromuscular Dysplasia (2015) (7)
- [Logical basis for the diagnosis of renovascular hypertension. Application to the treatment of atheromatous stenosis of the renal arteries]. (1990) (7)
- [Primary hyperaldosteronism: diagnostic value of the administration of a single dose of captopril]. (1983) (7)
- Teletransmission of home blood pressure monitoring: making it easier. (2008) (6)
- Automatic stenosis detection and quantification in renal arteriography (1997) (6)
- A "pivot" Model to set up Large Scale Rare Diseases Information Systems: Application to the Fibromuscular Dysplasia Registry (2015) (6)
- [Testing an expert system for hypertension]. (1986) (6)
- [Results of the surgical treatment of Conn's adenomas]. (1987) (6)
- About an epidemic of primary aldosteronism. (2008) (6)
- [A simple diagnostic test for primary hyperaldosteronism]. (1983) (6)
- [Update on endocrine hypertension]. (2012) (6)
- Study of glucagon secretion using in vitro perifusion of rat pancreas pieces. (1975) (5)
- CLINICAL PROFILE OF PATIENTS REFERRED TO A TERTIARY HYPERTENSION UNIT IN A CITY AREA: PP.15.52 (2010) (5)
- Variations with time of plasma concentrations of matrix metalloproteinases 2 and 9 and tissue inhibitors of metalloproteinases 1 and 2. (2007) (5)
- Masked hypertension : a systematic review. Commentary (2008) (5)
- [Adrenocortical scintigraphy with 131I-19-iodocholesterol. Indications and results in 66 cases of hypercortisolism and hyperaldosteronism (author's transl)]. (1981) (5)
- Stent treatment for pseudocoarctation and refractory hypertension in an elderly patient with Takayasu's arteritis. (2000) (5)
- [Maternal effects and perinatal safety of labetalol in the treatment of hypertension in pregnancy. Comparison with methyldopa in a randomized cooperative trial]. (1987) (5)
- [Treatment of arterial hypertension. Comparative effectiveness of the day care hospital and classical hospitalization]. (1983) (5)
- CO-43: Genetic study identifies common variation in phactr1 to associate with fibromuscular dysplasia. (2015) (5)
- [Recent advances in the investigation of the renin-angiotensin and cardiac natriuretic systems in patients with chronic heart insufficiency]. (1991) (4)
- [Incidence and fetal impact of hypertension in pregnancy: study of 2996 pregnancies]. (1982) (4)
- Clinical and biochemical characterization of antithrombin III Franconville, a variant with Pro 41 Leu mutation (1990) (4)
- Influence of educational and sociocultural factors on hypertension care. (1985) (4)
- [Malignant adrenal cortex carcinoma revealed by an isolated picture of primary hyperaldosteronism]. (1988) (4)
- Localizing value of catecholamine profile in patients with adrenal or ectopic pheochromocytoma. (1994) (4)
- [A computerized medical record for the follow-up of hypertensive patients (author's transl)]. (1980) (4)
- Abstract 15370: Genetic Study Identifies Common Variation in PHACTR1 to Associate With Fibromuscular Dysplasia (Best of Basic Science Abstract) (2015) (4)
- Atherosclerotic renal artery stenosis: Surgery, percutaneous transluminal angioplasty, or medical therapy? (2000) (4)
- [Evaluation of a computer assisted training program for hypertensive patients]. (1994) (4)
- Epithelioid sarcoma of soft tissues: a case of extrarenal renin-secreting tumour. (1988) (4)
- ESH-ENDORSED EUROPEAN/INTERNATIONAL FIBROMUSCULAR DYSPLASIA REGISTRY: RESULTS OF THE FIRST 609 PATIENTS (2018) (4)
- CARDIOVASCULAR COMPLICATIONS IN PATIENTS WITH PRIMARY HYPERALDOSTERONISM: A CONTROLLED CROSS-SECTIONAL STUDY: PP.18.178 (2010) (4)
- [Renal artery fibromuscular dysplasia]. (2011) (4)
- [Antinuclear antibodies and lupus induced during treatment of arterial hypertension. Role of beta-blockers and alpha-methyldopa]. (1983) (4)
- Noradrenaline producing phaeochromocytomas with absent pressor response to beta-blockade. (1979) (4)
- Male Sex Is Associated With Cervical Artery Dissection in Patients With Fibromuscular Dysplasia (2021) (4)
- SELECTION OF PATIENTS FOR SURGERY FOR PRIMARY ALDOSTERONISM (2008) (4)
- Renin Activity and the Response to Beta-Blockade (1981) (4)
- Compliance to Antihypertensive Therapy (1982) (3)
- [PP.25.14] RECURRENCE OR NEW TUMOURS AFTER COMPLETE RESECTION OF PHAEOCHROMOCYTOMAS AND PARAGANGLIOMAS: A SYSTEMATIC REVIEW AND META-ANALYSIS (2016) (3)
- In vitro glucocorticosteroid and mineralocorticosteroid biosynthesis in Conn’s adenoma tissues (1993) (3)
- [Presentations and management of adrenal hypertension]. (2014) (3)
- Test diagnostique simple de l'hyperaldostéronisme primaire. (1983) (3)
- B013: Comparison of telmisartan monotherapy with losartan + HCTZ in mild-to-moderate hypertension (2000) (3)
- [Renal-nerve ablation in patients with resistant hypertension: caution is still needed]. (2012) (3)
- IMPACT OF DIAGNOSTIC CRITERIA ON THE INTERPRETATION OF ADRENAL VENOUS SAMPLING RESULTS: 4D.03 (2010) (3)
- Renal artery stenosis and congestive heart failure. (1993) (3)
- BLOOD PRESSURE AND POTASSIUM EFFECTS OF THE NEW DIRECT ALDOSTERONE SYNTHASE INHIBITOR, LCI699, IN PATIENTS WITH PRIMARY ALDOSTERONISM: 9D.03 (2010) (3)
- [Value and limits of renal artery examination in the aged]. (1990) (3)
- Effect of captopril and other inhibitors of angiotensin-converting enzyme on plasma prolidase activity. (1988) (3)
- OMAPATRILAT IN PERSONS WITH ENHANCED RISK OF ATHEROSCLEROTIC EVENTS: THE OPERA TRIAL (2000) (3)
- Influence of beta-blockade on aldosterone metabolism under normal and low sodium diet in man. (1977) (2)
- COMPARISON OF TELMISARTAN MONOTHERAPHY WITH LOSARTAN + HYDROCHLOROTHIAZIDE IN MILD-TO-MODERATE HYPERTENSION: P2.33 (2000) (2)
- Interactions between antihypertensive agents, serum lipids and cigarette smoking in high risk hypertensive patients. (1989) (2)
- [Validation of an self-measurement blood pressure device]. (1988) (2)
- [Predictive factors of resistance to antihypertensive treatment]. (1987) (2)
- MANAGEMENT OF PHEOCHROMOCYTOMA – PARAGANGLIOMA (2019) (2)
- Use of plasma chromogranin A and urine fractionated metanephrines to diagnose pheochromocytoma? (2008) (2)
- [Revascularization of atherosclerotic stenosis of the renal artery. Indications and results]. (2001) (2)
- THE SDHB AND VHL GENES SHOULD BE SYSTEMATICALLY TESTED IN PATIENTS WITH NONSYNDROMIC PHEOCHROMOCYTOMA: P2.207 (2004) (2)
- [The Na+/H+ antiport: a target for new antihypertensive agents]. (1989) (2)
- SUPERIORITY OF LOW DOSE DIURETICS COMBINATION OVER RENIN-ANGIOTENSIN BLOCKERS COMBINATION IN RESISTANT HYPERTENSION: PP.16.89 (2010) (2)
- SERUM SODIUM TO URINARY SODIUM DIVIDED BY (SERUM POTASSIUM)2 TO URINARY POTASSIUM (SUSPPUP RATIO) AS A SCREENING TOOL FOR PRIMARY ALDOSTERONISM: PP.18.172 (2010) (2)
- [Access to medical care of patient with hypertension: influence of socio-professional categories (author's transl)]. (1980) (2)
- Renal artery stenosis and congestive heart failure (1993) (2)
- [Renovascular hypertension: diagnostic and therapeutic strategy]. (1992) (2)
- The importance of diabetes as a cardiovascular risk factor. (2000) (2)
- [Comparison of 3 methods of blood pressure measurement in obesity]. (1988) (2)
- [Pheochromocytoma and pregnancy. Case report]. (2006) (2)
- H54: Efficacy and safety of candesartan cilexetil in combination with hydrochlorothiazide (HCTZ) in the treatment of patients with mild to moderate hypertension unresponsive to HCTZ alone (1997) (2)
- Structural and functional arterial abnormalities in fibromuscular dysplasia are in the continuum of hypertension: an imaging and biomechanical study (2016) (2)
- Pheochromocytoma of the Urinary Bladder (2002) (2)
- Possible Implication of the Renin-Angiotensin-Aldosterone System in the Hypertension of Phaeochromocytoma (1985) (2)
- The influence of diagnostic criteria on the interpretation of adrenal venous sampling (2014) (2)
- [Critical evaluation of the functional signs of arterial hypertension]. (1982) (2)
- [Achievements of the COMETE program in the genetics of pheochromocytoma]. (2008) (2)
- [Renovascular arterial hypertension. Evaluation of ultrasonographic measurement of kidney length]. (1992) (2)
- IgG versus albumin for measurement of plasma volume in normal and hypertensive men (1978) (1)
- Abstract P137: Socioeconomic Status And Hypertension Control In Sub-saharan Africa: The Multination Eight Study (2018) (1)
- CAPPP trial (1999) (1)
- [From clinical observation to assessment of practices: guidelines for hypertension management]. (2009) (1)
- REFRACTORY HYPERTENSION: EFFICACY AND SAFETY OF A TRIPLE DIURETIC ASSOCIATION (2004) (1)
- Adrenal tumours and hormone excess. Editorial. (2009) (1)
- Images in cardiovascular medicine. Pheochromocytoma of the urinary bladder. (2002) (1)
- [Endocrine hypertension in pregnancy]. (2002) (1)
- [Phaeochromocytoma: localisation by computerised scanner tomography. 5 cases (author's transl)]. (1979) (1)
- ACE inhibitors and diabetics with albuminuria. The DIABHYCAR Study Group. (1995) (1)
- Ethnicity and socio-economic inequalities in malignant hypertension. (2006) (1)
- ACE inhibitors and diabetics with albuminuria (1995) (1)
- ACE inhibitors, cough, and genetics. (1994) (1)
- [Non-surgical treatments of renal artery stenoses]. (1996) (1)
- The Antlhypertensive Effect of Nicardipine (Long-Acting Form), Renin Activity and Divalent Cations (1985) (1)
- Sarcoidosis presenting as severe renin-dependent hypertension due to kidney vascular injury (2014) (1)
- Chapter 66 – Renin-Secreting Tumors and Other Renin-Secreting States (2007) (1)
- INFLUENCE OF RENAL ARTERY DENERVATION ON BLOOD PRESSURE VARIABILITY AND BAROREFLEX SENSITIVITY: A PROSPECTIVE CONSECUTIVE CASE-SERIES: 4A.06 (2011) (1)
- 5. Single intravenous nicardipine dose: a new diagnosis test in renovascular hypertension (1991) (1)
- Transluminal vascular stents for ostial atherosclerotic renal artery stenosis (1995) (1)
- [Comparison of the effect of captopril and minoxidil on left ventricular mass. Results of a 6-month comparative double-blind test]. (1987) (1)
- [A new diagnostic test for primary tumoral hyperaldosteronism]. (1983) (1)
- 10 Evaluation of a computer‐assisted education program for hypertensive patients (1994) (1)
- 5. Split and global renal function in hypertensive patients following successful percutaneous transluminal renal angioplasty for unilateral renal artery stenosis (1995) (1)
- [Transluminal angioplasty in renovascular hypertension with renal insufficiency]. (1988) (1)
- RARE LOSS-OF-FUNCTION MUTATIONS OF PTGIR IDENTIFIED IN FIBROMUSCULAR DYSPLASIA AND SPONTANEOUS CORONARY ARTERY DISSECTION (2019) (1)
- β-Adrenoceptor Blocking Drugs and the Renin-Angiotensin System (1980) (1)
- [Antihypertensive drugs prescribed to patients before their first consultation in a hypertension unit: comparison between 2001 and 2006]. (2008) (1)
- Fuzzy classification of renal artery lesions from angiograms in the context of angioplasty. (1997) (1)
- The ARTEMIS data and knowledge base for hypertension (1991) (1)
- Urgences hypertensives de l'adulte (2010) (1)
- [Acute response to calcium inhibitors in secondary arterial hypertension: does renin play a role?]. (1988) (1)
- Prevalence and etiologies of endocrine hypertension (2006) (1)
- THE ADRENAL VEIN SAMPLING INTERNATIONAL STUDY (AVIS) ON USE AND INTERPRETATION OF ADRENAL VEIN SAMPLING FOR DIFFERENTIATING THE MAJOR SUBTYPES OF PRIMARY ALDOSTERONISM: 8D.07 (2011) (1)
- [Left ventricular involvement in Conn adenoma, renovascular hypertension and pheochromocytoma before and after etiological treatment]. (1992) (1)
- Differential transcription of 11[beta]-hydroxylase and aldosterone synthase alleles in human adrenocortical tissue (2009) (1)
- HORMONAL EFFECTS OF THE NEW DIRECT ALDOSTERONE SYNTHASE INHIBITOR, LCI699, IN PATIENTS WITH PRIMARY ALDOSTERONISM: 5C.06 (2010) (1)
- [Hypertensive emergencies in adults: a practical review]. (2010) (0)
- Response to implementation of rapid cortisol during adrenal vein sampling. (2014) (0)
- [Coronary disease prevention in diabetic hypertension: intervention thresholds and therapeutic methods]. (1997) (0)
- [Management of atherosclerotic renal artery stenoses]. (2002) (0)
- [Is reversal of left ventricular hypertrophy a priority in patients with hypertension?]. (1995) (0)
- [PP.07.07] CIRCULATING MICROVESICLES (C-MVS) LEVELS AND ENDOTHELIAL FUNCTION IN PATIENTS WITH MULTIFOCAL FIBROMUSCULAR DYSPLASIA (FMD): A CROSS-SECTIONAL STUDY (2016) (0)
- [OP.1C.06] HIGH PREVALENCE OF MULTISITE FIBROMUSCULAR DYSPLASIA: THE ARCADIA (ASSESSMENT OF RENAL AND CERVICAL ARTERY DYSPLASIA) REGISTRY (2016) (0)
- Potential role of mast cells in the physiopathology of aldosterone-producing adenoma (2011) (0)
- [The beta-blockers in hypertension]. (1984) (0)
- Experimental Assessment of the Role of an Expert System in Hypertension (1986) (0)
- [Pharmacology of converting enzyme inhibitors (captopril and related products)]. (1982) (0)
- [PP.25.17] EFFECT OF RENAL ARTERY ANGIOPLASTY ON AMBULATORY BLOOD PRESSURE IN PATIENTS WITH RESISTANT HYPERTENSION AND ATHEROSCLEROTIC RENAL ARTERY STENOSIS (2017) (0)
- Un exemple d'association acceptable dans le traitement de l'hypertension artérielle. (1978) (0)
- [Incidence of beta-blockers on plasma renin activity. Present status]. (1978) (0)
- Progression-free survival without treatment of malignant pheochromocytoma and paraganglioma at one year (2012) (0)
- 45th ESCP-NSF international symposium on clinical pharmacy: clinical pharmacy tackling inequalities and access to health care. Oslo, Norway, 5–7 October 2016 (2017) (0)
- OS 04-02 HIGH PREVALENCE OF MULTISITE FIBROMUSCULAR DYSPLASIA: THE ARCADIA REGISTRY. (2016) (0)
- [The individual risk of hypertensive patients: from assessment to treatment. Comments on the first session]. (1997) (0)
- Hypertension in Practice (2000) (0)
- [Effects of acebutolol on the renin-aldosterone system in essential arterial hypertension]. (1975) (0)
- [Cervical and intracranial fibromuscular dysplasia]. (2011) (0)
- Patient Compliance in Hypertension Care: The Critical Role of the Computer (1982) (0)
- Iconography : Hypertension artérielle endocrine (2010) (0)
- Malignant pheochromocytomas or paragangliomas (2010) (0)
- Scintigraphie surrénale : Resultats dans les hyperaldostéronismes primaires et les hypercortisolismes à propos de 62 casAdrenal scanning: Results in 62 subjects with primary hyperaldosteronism and hypercortisolism (1980) (0)
- FEASIBILITY OF ESTIMATING FIBROMUSCULAR DYSPLASIA PREVALENCE USING HEALTH ADMINISTRATIVE DATABASE: A NATIONWIDE STUDY (2018) (0)
- Phaeochromocytoma as presenting manifestation of Von Hippel-Lindau disease: (1992) (0)
- [Diuretics in arterial hypertension]. (1986) (0)
- 15th Meeting of the French Hypertension Society Palais des Congrès, Paris, 14–15 December 1995: Comparative study of traditional and endoscopic surgery of Conn's adenoma (1997) (0)
- [Medico social management of severe hypertension]. (2013) (0)
- [Interest in multifactorial prevention of coronary disease in hypertensives: use of beta blockaders]. (1979) (0)
- [The decision to treat moderate hypertension: repetition of office visits or ambulatory monitoring of arterial pressure?]. (1987) (0)
- Abstract No. 31: Catheter-based renal sympathetic denervation for the treatment of uncontrolled hypertension: An overview of technology, technique and recent clinical experience (2011) (0)
- [Use of beta blockaders in the treatment of arterial hypertension]. (1975) (0)
- [Plasma renin and noradrenalin levels during hypotensive therapy using acebutolol (author's transl)]. (1979) (0)
- [Giant pheochromocytoma mimicking hepatoma]. (1980) (0)
- Angioplasty vs medical therapy in the treatment of unilateral atherosclerotic renal artery stenosis: A prospective randomized open blinded-endpoint trial (1997) (0)
- Prevalence and Determinants of Non-rheumatic Atrial Fibrillation (AF) in Patients With Primary Aldosteronism (1998) (0)
- Response to Metabolic Dysfunction in Primary Aldosteronism (2009) (0)
- [Influence of sex hormones on the arterial pressure]. (1994) (0)
- MANAGEMENT OF PHEOCHROMOCYTOMAñPARAGANGLIOMA (2010) (0)
- [Management of hypertensive crises and refractory hypertension]. (1990) (0)
- Noradrenaline producing phaeochromocytomas with (1979) (0)
- [Hypertension of adrenal origin: the experience of a medicosurgical team from 1975 to 1979]. (1980) (0)
- Human Cancer Biology MAX Mutations Cause Hereditary and Sporadic Pheochromocytoma and Paraganglioma (2012) (0)
- [Hypertension excellence centers]. (2010) (0)
- [Does hypertension have fewer complications in pregnancy in obese patients?]. (1987) (0)
- PREDICTIVE FACTORS OF BLOOD PRESSURE CONTROL IN RESISTANT HYPERTENSION TREATED BY SEQUENTIAL NEPHRON BLOCKADE VS SEQUENTIAL RENIN ANGIOTENSIN SYSTEM BLOCKADE: 9A.04 (2011) (0)
- CAPPP trial. Captopril Prevention Project. (1999) (0)
- [Treatment of hypertension: present and perspectives]. (2012) (0)
- [Endocrine hypertension]. (2010) (0)
- Management of phaeochromocytomas and paragangiolomas (2011) (0)
- FEATURES AT PRESENTATION AND RISK OF RECURRENCE IN PATIENTS WITH PHEOCHROMOCYTOMA: P2.116 (2004) (0)
- [The evaluation of arterial hypertension in a patient with arteritis is central to the assessment of renal artery stenosis]. (2005) (0)
- CO-14: Assessment of patients attending hypertension consultations at University Hospital Georges Pompidou in the last 15 years. (2015) (0)
- [Fibromuscular dysplasia]. (2007) (0)
- VIDEO TRAINING FOR BLOOD-PRESSURE SELF-MEASUREMENT: P2.18 (2004) (0)
- [Arterial hypertension and social inequalities]. (1979) (0)
- Reply: diagnosis and management of fibromuscular dysplasia. (2014) (0)
- [Is it still necessary to look for the surgically-treatable causes of arterial hypertension?]. (1981) (0)
- [Arterial hypertension: risk factor in atheroma]. (1982) (0)
- the(causative)relationshipbetweenanatomicalabnormali- ties and changes in renal function. (2014) (0)
- [Can we reduce the cardiovascular risk in hypertensive patients?]. (1998) (0)
- OS 04-02 HIGH PREVALENCE OF MULTISITE FIBROMUSCULAR DYSPLASIA: THE ARCADIA REGISTRY (2016) (0)
- [Indication and choice of diuretic treatment]. (1978) (0)
- Subject Index Vol. 58, 2000 (2000) (0)
- [Calcium inhibitors and treatment of arterial hypertension]. (1988) (0)
- [Adrenal hypertension]. (2008) (0)
- Points: A plain man's guide to the management of migraine (1982) (0)
- [When and how to undertake antihypertensive treatment in a diabetic]. (1993) (0)
- [Renovascular hypertension. Concepts and reality]. (1979) (0)
- High Blood Pressure and the Risk of Stroke (2006) (0)
- Common carotid artery wall subclinical lesions are present in subjects with renal fibromuscular dysplasia (2012) (0)
- [Kidneys, hypertension and pregnancy. I. Renal function in normal pregnancy (author's transl)]. (1982) (0)
- [Should angioplasty still be considered for atherosclerotic renal artery stenosis?]. (2001) (0)
- [Monitoring of diuretic treatment. Research on complications]. (1978) (0)
- Polymorphic variation in the aldosterone synthase gene (CYP11B2) in aldosterone-producing adenomas (2000) (0)
- Q001: The answer to “What is my BP, doctor?” Depends on whom is asked (1998) (0)
- [With which drug should the general practitioner begin antihypertensive treatment: a diuretic of a beta blocker?]. (1977) (0)
- Optimal management of hypertensive patients with LVH and dyslipidaemia. (1998) (0)
- [Disorders of carbohydrate metabolism induced by steroid contraceptive agents]. (1975) (0)
- [Current clinical use of converting enzyme inhibitors]. (1982) (0)
- Spectre clinique de lhyperaldostronisme primaire: tude dune cohorte franaise de 124 patients (1997) (0)
- [Use of intravenous nicardipine for the diagnosis of renovascular hypertension]. (1991) (0)
- The relationship between functional arterial response and circulating biomarkers of patients with fibromuscular dysplasia (2016) (0)
- [Angioplasty for atherosclerotic renal artery stenosis: the end of the story?]. (2014) (0)
- THE HIF-PATHWAY, NEW CANDIDATE GENES FOR PARAGANGLIOMA AND/OR PHEOCHROMOCYTOMA?: P1.201 (2004) (0)
- B9 - Plasma levels of potassium, aldosterone, renin, and the aldosterone/renin ratio in patients with aldosterone-producing adenoma: Relation to diagnosis and blood pressure outcome (1995) (0)
- J10 Left ventricular mass and radial artery wall thickness in primary aldosteronism (PA) and essential hypertension (EH) (1997) (0)
- [Iodo-methyl norcholesterol scintigraphy in the localization of primary hyperaldosteronism]. (1989) (0)
- HOME SELF BLOOD-PRESSURE MEASUREMENT: PATIENT EXPERIENCES (2004) (0)
- [Plasma renin and catecholamine activity in pheochromocytoma]. (1985) (0)
- [Symptoms and cardiovascular complications of the withdrawal of beta-blocker treatment. Practical implications]. (1984) (0)
- Optimisation du test génétique du phéochromocytome : détection des remaniements de grande taille par QMPSF (quantitative multiplex PCR of short fluorescent fragments) (2007) (0)
- ISIS: a computer-assisted education program for hypertensive patients and patients at cardiovascular risk (1994) (0)
- [Residual arterial hypertension after excision of an extra-adrenal pheochromocytoma]. (1986) (0)
- [Relations between family history of essential hypertension and fetal prognosis in hypertension in pregnancy]. (1989) (0)
- INVESTIGATION OF THE 9P21 LOCUS AS A SUSCEPTIBLE LOCUS FOR RENAL ARTERIAL FIBROMUSCULAR DYSPLASIA: 9D.02 (2011) (0)
- [Alpha-blockers in practice: classification and therapeutic use]. (1981) (0)
- Evaluation of a standardized protocol for the collection and storage of adrenal tumor samples preparation for an European adrenal tumor bank (ENS@T) (2006) (0)
- CHARACTERISTICS OF CONTROLLED VS. RESISTANT ESSENTIAL HYPERTENSIVE PATIENTS AFTER A STANDARDIZED 4-WEEK THREE DRUG-REGIMEN: PP.43.372 (2011) (0)
- Comparison Trial of Drug Intervention and Dietary Intervention in Overweight Hypertensive Patients (1986) (0)
- [Arterial hypertension: a specialty of the general practitioner]. (1979) (0)
- [Simultaneous measurement of cardiac output by indium 113 m detected externally and by dye dilution of indocyanine green]. (1977) (0)
- [Effects of minoxidil on blood pressure and plasma volume in refractory hypertension (author's transl)]. (1979) (0)
- Low angiotensinogen levels as an index of severity in heart failure. Consequence for renin measurement (1990) (0)
- [Labile hypertension (author's transl)]. (1977) (0)
- [Diuretics and cardiovascular outcome in hypertensive patients: an update]. (2003) (0)
- [Primary hyperaldosteronism]. (1998) (0)
- Does stenting for atherosclerotic renovascular disease improve blood pressure and kidney function better than medical treatment? (2009) (0)
- P-591: Effects of slow-release octreotide in patients with malignant or recurrent pheochromocytoma (2003) (0)
- [Fibromuscular dysplasia of renal arteries]. (2016) (0)
- [Blood pressure auto-measurement]. (1981) (0)
- [From sclerosis to vascular risk. The unknown contribution of life insurance]. (1994) (0)
- [Why look for secondary hypertension?]. (2015) (0)
- [Patients operated on for pheochromocytoma: biological surveillance]. (1999) (0)
- In-Depth Review Atherosclerotic renovascular disease: beyond the renal artery stenosis (2007) (0)
- Masked hypertension: a syste matic review (2008) (0)
- HYPERTENSION FOLLOWING RENAL TRAUMA: PREVALENCE, PRESENTATION AND OUTCOME (2004) (0)
- Aldosterone changes during angiotensin III and potassium infusions in patients with primary aldosteronism (1996) (0)
- The application of molecular genetics to the study of familial arterial hypertension. (1989) (0)
- [Recent development of recommendations for the screening and treatment of arterial hypertension]. (2002) (0)
- BIOCHEMICAL DIAGNOSIS OF PHEOCHROMOCYTOMA: COMPARISON OF URINARY METANEPHRINES WITH FREE AND TOTAL PLASMA METANEPHRINES (2004) (0)
- [Kidneys; hypertension and pregnancy. III. The renal risk in pregnancy]. (1982) (0)
- Abstract 49: Male Sex is Associated With Cervical Artery Dissection in Patients With Fibromuscular Dysplasia (2020) (0)
- Reviewucing adenoma and other surgically correctable forms of primary aldosteronism (2010) (0)
- 0382 : Exome sequencing in seven families and gene-based association studies indicate genetic heterogeneity and suggest possible candidates for fibromuscular dysplasia (2015) (0)
- [Detection of silent ischemia in hypertensive subjects with high vascular risk using continuous electrocardiogram in real time]. (1989) (0)
- Magnetic Resonance Imaging in Adrenal Hypertension: Preliminary Results in 21 Patients (1986) (0)
- [The treatment of hypertension in pregnancy (author's transl)]. (1982) (0)
- [The treatment of hypertension: long-term strategy]. (1979) (0)
- VASOPEPTIDASE-INHIBITOR OMAPATRILAT (1999) (0)
- Detection of large rearrangements in the pheochromocytomas genes using QMPSF (quantitative multiplex PCR of short fluorescent fragments): improvement of genetic testing (2007) (0)
- [Effect of alpha inhibitors on risk cofactors in patients with hypertension]. (1989) (0)
- [Hypertension, catecholamine hypersecretion and potential for metastasis: recent progress in the pathophysiology and genetics of pheochromocytoma and paraganglioma]. (2015) (0)
- [Influence of recent trials on essential arterial hypertension management]. (2004) (0)
- H44 Effect of antihypertensive therapy on cognitive function, mood and quality of life in elderly patients: A comparison of ramipril with nitrendipine (1997) (0)
- Isolated Clinical Syndrome of Primary Aldosteronism in Four Patients With Adrenocortical Carcinoma (1988) (0)
- A RETROSPECTIVE STUDY ON THE TAILORING OF SCORE CHARTS IN A SPECIALIZED TERTIARY HYPERTENSION UNIT (2018) (0)
- [Measurement of platelet catecholamine content for the diagnosis of pheochromocytoma with intermittent hypertension]. (1987) (0)
- [OP.7C.04] GENETIC ASSOCIATION STUDY IDENTIFIES COMMON VARIATION IN PHACTR1 TO ASSOCIATE WITH FIBROMUSCULAR DYSPLASIA (2016) (0)
- [The renin-angiotensin system and its inhibition (author's transl)]. (1981) (0)
- [Kidneys, hypertension and pregnancy. II. Hypertension in pregnancy: significance, prognosis, and treatment (author's transl)]. (1982) (0)
- [An example of an acceptable combination in the treatment of arterial hypertension]. (1978) (0)
- [Pheochromocytoma: 25 years of experience. Report of 199 cases]. (2003) (0)
- Autocrine-paracrine pathways in primary adrenal disorders (2007) (0)
- Beneficial effect of sequential nephron blockade of central pressure and large artery remodelling in resistant hypertension (2013) (0)
- BLOOD PRESSURE OUTCOME FOLLOWING ACUTE SEGMENTAL RENAL INFARCTION: P1.210 (2004) (0)
- COMPARISON OF BLOOD PRESSURE, POTASSIUM, RENIN AND ALDOSTERONE EFFECTS OF ALDOSTERONE SYNTHASE INHIBITION VS. MINERALOCORTICOID BLOCKADE IN PATIENTS WITH PRIMARY ALDOSTERONISM: 4A.02 (2011) (0)
- GENETIC STUDY OF PHACTR1 AND FIBROMUSCULAR DYSPLASIA, META-ANALYSIS AND EFFECTS ON CLINICAL FEATURES OF PATIENTS (2019) (0)
- [Recommendations for the management of patients with severe arterial hypertension. Commission IV. Cardiovascular Diseases]. (2012) (0)
- Apports de COMETE à la génétique du phéochromocytome. Discussion (2008) (0)
- Contents Vol. 58, 2000 (2000) (0)
This paper list is powered by the following services: